Patents Assigned to CMTx Biotech Inc.
  • Methods of treating charcot-marie-tooth disease
    Patent number: 12636293
    Abstract: A method of treating Charcot Marie Tooth Disease in a human in need thereof. The method comprises systemically administering to the human a non-antibacterial tetracycline compound or antibacterial tetracycline compound, in an amount that is effective to treat Charcot Marie Tooth Disease but has substantially no antibacterial activity.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: May 26, 2026
    Assignee: CMTx Biotech Inc.
    Inventor: Joseph Scaduto
  • METHODS OF TREATING ILLNESSES CAUSED BY CORONAVIRUS, SWINE FLU AND AVIAN FLU
    Publication number: 20230113011
    Abstract: A method of treating COVID-19 in a human in need thereof. The method comprises administering a tetracycline compound in an amount that is effective to treat COVID-19, but has substantially no antibacterial activity.
    Type: Application
    Filed: March 12, 2021
    Publication date: April 13, 2023
    Applicant: CMTx Biotech Inc.
    Inventors: Joseph Scaduto, James Keane